Transmission of Ebola viruses: What we know and what we do not know

mBio

Volumn 6, Issue 2, 2015, Pages

  Osterholm, Michael T ^a   Moore, Kristine A ^a   Kelley, Nicholas S ^a   Brosseau, Lisa M ^b   Wong, Gary ^c   Murphy, Frederick A ^d   Peters, Clarence J ^d   LeDuc, James W ^d   Russell, Phillip K ^e   Van Herp, Michel ^f   Kapetshi, Jimmy ^g   Muyembe, Jean Jacques T ^g   Ilunga, Benoit Kebela ^h   Strong, James E ^c   Grolla, Allen ^c   Wolz, Anja ^f   Kargbo, Brima ⁱ   Kargbo, David K ⁱ   Formenty, Pierre ^j   Sanders, David Avram ^k   Kobinger, Gary P ^c   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e SABIN VACCINE INSTITUTE   (United States)

^f Medical Department   (Belgium)

^g Direction of the institute   (Democratic Republic Congo)

^h Ministry of Health   (Democratic Republic Congo)

ⁱ MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k PURDUE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

AIRBORNE INFECTION; ARTICLE; ASYMPTOMATIC INFECTION; BODY FLUID; DOMESTIC ANIMAL; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FOMITE; GENOMICS; HOSPITAL INFECTION; HUMAN; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; VIRAL CONTAMINATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS PARTICLE; VIRUS SHEDDING; VIRUS TRANSMISSION; ZOONOSIS; AFRICA; ANIMAL; DISEASE TRANSMISSION; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; TRANSMISSION; VIROLOGY;

ANIMALIA; EBOLA VIRUS;

AFRICA, WESTERN; ANIMALS; DISEASE TRANSMISSION, INFECTIOUS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; ZOONOSES;

EID: 84929332445     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00137-15     Document Type: Article

References (86)

1. WHO. 2014. Ebola virus disease: fact sheet. http://www.who.int/mediacentre/factsheets/fs103/en/.
2. Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga BK, Kabange F, Kingebeni P, Mondonge V, Muyembe JJ, Bertherat E, Briand S, Cabore J, Epelboin A, Formenty P, Kobinger G, González-Angulo L, Labouba I, Manuguerra J-C, Okwo-Bele J-M, Dye C, Phil D, Leroy EM. 2014. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 371:2083–2091. http://dx.doi.org/10.1056/NEJMoa1411099.
3. Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A Fulhorst CF, Rollin, PE, Calaor AB, Manalo DL, Roces MC, Dayrit MM, Peters CJ. 1999. Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis 179(Suppl):S115–S119.
4. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 155:2083–2103. http://dx.doi.org/10.1007/s00705-010-0814-x.
5. Miranda ME, Miranda NL. 2011. Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis 204(Suppl 3):S757–S760. http://dx.doi.org/10.1093/infdis/jir296.
6. International Commission. 1978. Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ 56:247–270.
7. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Ker-stiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Ksiazek TG, De Lutte C. 1999. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1):S76–S86. http://dx.doi.org/10.1086/514306.
8. WHO Ebola Response Team. 2014. Ebola virus disease in West Africa— the first 9 months of the epidemic and forward projections. N Engl J Med 371:1481–1495. http://dx.doi.org/10.1056/NEJMoa1411100.
9. Chan M. 2014. Ebola virus disease in West Africa—no early end to the outbreak. N Engl J Med 371:1183–1185. http://dx.doi.org/10.1056/NEJMp1409859.
10. Reeve M, Altevogt B. 2014. Research priorities to inform public health and medical practice for Ebola virus disease: workshopinbrief. Institute of Medicine, National Academies, Washington, DC.
11. International Commission. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56:271–293.
12. Matanock A, Arwady MA, Ayscue P, Forrester JD, Gaddis B, Hunter JC, Monroe B, Pillai SK, Reed C, Schafer IJ, Massaquoi M, Dahn B, De Cock KM. 2014. Ebola virus disease cases among health care workers not working in Ebola treatment units—Liberia, June–August, 2014. MMWR Morb Mortal Wkly Rep 63:1077–1081.
13. Kerstiëns B, Matthys F. 1999. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1): S263–S267. http://dx.doi.org/10.1086/514320.
14. Guimard Y, Bwaka MA, Colebunders R, Calain P, Massamba M, De Roo A, Mupapa KD, Kibadi K, Kuvula KJ, Ndaberey DE, Katwiki KR, Mapanda BB, Nkuku OB, Fleerackers Y, Van den Enden E, Kipasa MA. 1999. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1):S268–S273.
15. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, Amone J, Mbabazi W, Nanyunja M, Zaramba S, Opio A, Lutwama JJ, Talisuna AO, Okware SI. 2010. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008. Emerg Infect Dis 16:1087–1092. http://dx.doi.org/10.3201/eid1607.091525.
16. Oyok T, Odonga C, Mulwani E, Abur J, Kaducu F, Akech M, Olango J, Onek P. 2001. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep 50:73–77.
17. Baron RC, McCormick JB, Zubeir OA. 1983. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61:997–1003.
18. Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, An-draghetti R, Rollin PE, Opira C, Greco D, Salmaso S. 2003. Ebola hemor-rhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 9:1430–1437. http://dx.doi.org/10.3201/eid0911.030339.
19. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. 1999. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republicof the Congo, 1995.J Infect Dis 179(Suppl 1):S87–S91. http://dx.doi.org/10.1086/514284.
20. Roels TH, Bloom AS, Buffington J, Muhungu GL, MacKenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, Ksiazek TG. 1999. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 179(Suppl 1):S92–S97.
21. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. 2007. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196(Suppl 2):S142–S147. http://dx.doi.org/10.1086/520545.
22. Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C. 2006. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 42:1521–1526. http://dx.doi.org/10.1086/503836.
23. Richards GA, Murphy S, Jobson R, Mer M, Zinman C, Taylor R, Swanepoel R, Duse A, Sharp G, De La Rey IC, Kassianides C. 2000. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 28:240–244. http://dx.doi.org/10.1097/00003246-200001000-00041.
24. Rowe AK, Bertolli J, Khan AS, Mukunu R, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG. 1999. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 179(Suppl 1):S28–S35. http://dx.doi.org/10.1086/514318.
25. Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A, Bressler D, Williams AJ, Rowe AK, Bertolli J, Khan AS, Ksiazek TG, Peters CJ, Nichol ST. 1999. Persistence and genetic stability ofEbola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179:S170–S16.
26. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, Sow A, Renné T, Günther S, Lohse AW, Addo MM, Schmiedel S. 2014. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371:141022140021004. http://dx.doi.org/10.1056/NEJMoa1411677.
27. Zaki SR, Goldsmith CS. 1999. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 235:97–116. http://dx.doi.org/10.1007/978-3-642-59949-1_7.
28. WHO. 2014. Ebola virus in semen of men who have recovered from Ebola virus disease. http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/.
29. Sagripanti J-L, Lytle CD. 2011. Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Arch Virol 156: 489–494. http://dx.doi.org/10.1007/s00705-010-0847-1.
30. Sagripanti J-L, Rom AM, Holland LE. 2010. Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch Virol 155:2035–2039. http://dx.doi.org/10.1007/s00705-010-0791-0.
31. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 109:1531–1539. http://dx.doi.org/10.1111/j.1365-2672.2010.04778.x.
32. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, George-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick J, Georges AJ. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210–2215. http://dx.doi.org/10.1016/S0140-6736(00)02405-3.
33. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R, Nichol ST, Lee WF, Nichol ST. 2004. Rapid diagnosis of Ebola hem-orrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78: 4330–4341. http://dx.doi.org/10.1128/JVI.78.8.4330-4341.2004.
34. Borchert M, Mutyaba I, Van Kerkhove MD, Lutwama J, Luwaga H, Bisoborwa G, Turyagaruka J, Pirard P, Ndayimirije N, Roddy P, Van Der Stuyft P. 2011. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis 11:357. http://dx.doi.org/10.1186/1471-2334-11-357.
35. WHO. 2014. Sierra Leone: a traditional healer and a funeral. http://www.who.int/csr/disease/ebola/ebola-6-months/sierra-leone/en/.
36. Franz DR, Jahrling PB, McClain DJ, Hoover DL, Byrne WR, Pavlin JA, Christopher GW, Cieslak TJ, Friedlander AM, Eitzen EM. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399–411.
37. WHO. 2014. Unprecedented number of medical staff infected with Ebola. http://www.who.int/mediacentre/news/ebola/25-august-2014/en/.
38. Chevalier MS, Chung W, Smith J, Weil LM, Hughes SM, Joyner SN, Hall E, Srinath D, Ritch J, Thathiah P, Threadgill H, Cervantes D, Lakey DL, Centers for Disease Control and Prevention (CDC). 2014. Ebola virus disease cluster in the United States—Dallas county, Texas, 2014. MMWR Morb Mortal Wkly Rep 63:1087–1088.
39. Parra JM, Salmerón OJ, Velasco M. 2014. The first case of Ebola virus disease acquired outside Africa. N Engl J Med 371:2439–2440. http://dx.doi.org/10.1056/NEJMc1412662.
40. Formenty P, Boesch C, Wyers M, Steiner C, Donati F, Walker F, Le Guenno B. 1999. Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d’ Ivoire. J Infect Dis 179:S120–S126. http://dx.doi.org/10.1086/514296.
41. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A. 1999. Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis 179(Suppl):S48–S53. http://dx.doi.org/10.1086/514285.
42. Leroy EM, Rouquet P, Formenty P, Kilbourne A, Froment J, Ber-mejo M, Smit S, Karesh W, Swanepoel R, Zaki SR, Rollin PE. 2004. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303:387–391. http://dx.doi.org/10.1126/science.1092528.
43. WHO. 2003. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Wkly Epidemiol Rec 78:223–228.
44. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez J-P, Muyembe-Tamfum J-J, Formenty P. 2009. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of the Congo, 2007. Vector Borne Zoonotic Dis 9:723–728. http://dx.doi.org/10.1089/vbz.2008.0167.
45. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez J-P, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575–576. http://dx.doi.org/10.1038/438575a.
46. WHO. 1992. Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec 67:142–143.
47. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ. 1990. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335:502–505. http://dx.doi.org/10.1016/0140-6736(90)90737-P.
48. WHO. 2009. WHO experts consultation on Ebola Reston pathogenicity in humans. http://www.who.int/csr/resources/publications/HSE_EPR_2009_2.pdf.
49. Marsh GA, Haining J, Robinson R, Foord A, Yamada M, Barr JA, Payne J, White J, Yu M, Bingham J, Rollin PE, Nichol ST, Wang L-F, Middleton D. 2011. Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis 204(Suppl 3):S804–S809. http://dx.doi.org/10.1093/infdis/jir300.
50. Allela L, Boury O, Pouillot R, Délicat A, Yaba P, Kumulungui B, Rouquet P, Gonzalez JP, Leroy EM. 2005. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis 11:385–390. http://dx.doi.org/10.3201/eid1103.040981.
51. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. 1995. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 346: 1669–1671. http://dx.doi.org/10.1016/S0140-6736(95)92841-3.
52. CDC. 2014. Review of human-to-human transmission of Ebola virus. http://www.cdc.gov/vhf/ebola/transmission/human-transmission.html.
53. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G. 2012. Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2:811. http://dx.doi.org/10.1038/srep00811.
54. Alimonti J, Leung A, Jones S, Gren J, Qiu X, Fernando L, Balcewich B, Wong G, Ströher U, Grolla A, Strong J, Kobinger G. 2014. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep 4:5824. http://dx.doi.org/10.1038/srep05824.
55. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M, Jahrling PB. 1996. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virusbythe oral and conjunctival route ofexposure. Arch Pathol Lab Med 120:140–155.
56. Johnson E, Jaax N, White J, Jahrling P. 1995. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 76:227–236.
57. Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM. 2011. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 204: 200–208. http://dx.doi.org/10.1093/infdis/jir077.
58. Kuhn JH. 2008. Filoviruses:a compendium of40yearsof epidemiological, clinical, and laboratory studies. Springer-Verlag, Vienna, Austria.
59. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. 2015. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 235:153–174. http://dx.doi.org/10.1002/path.4456.
60. Twenhafel NA, Mattix ME, Johnson JC, Robinson CG, Pratt WD, Cashman KA, Wahl-Jensen V, Terry C, Olinger GG, Hensley LE, Honko AN. 2013. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques. Vet Pathol 50:514–529. http://dx.doi.org/10.1177/0300985812469636.
61. Twenhafel NA, Shaia CI, Bunton TE, Shamblin JD, Wollen SE, Pitt LM, Sizemore DR, Ogg MM, Johnston SC. 2015. Experimental aerosolized guinea pig-adapted Zaire Ebolavirus (variant: Mayinga) causes lethal pneumonia in guinea pigs. Vet Pathol 52:21–25. http://dx.doi.org/10.1177/0300985814535612.
62. Wong G, Qiu X, Richardson JS, Cutts T, Collignon B, Gren J, Aviles J, Embury-Hyatt C, Kobinger GP. 2015. Ebola virus transmission in guinea pigs. J Virol 89:1314–1323. http://dx.doi.org/10.1128/JVI.02836-14.
63. Sanchez A, Ksiazek TG, Rollin PE, Miranda ME, Trappier SG, Khan AS, Peters CJ, Nichol ST. 1999. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 179:S164–S169.
64. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba M, Soropogui B, Sow MS, Keïta S. 2014. Emergence of Zaire Ebola virus disease in Guinea—preliminary report. N Engl J Med 371:1418–1425. http://dx.doi.org/10.1056/NEJMoa1404505.
65. Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, et al. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369–1372. http://dx.doi.org/10.1126/science.1259657.
66. Volz E, Pond S. 2014. Phylodynamic analysis of Ebola virus in the 2014 Sierra Leone epidemic. PLoS Curr Outbreaks 1:1–17.
67. Stadler T, Kühnert D, Rasmussen DA, Plessis L. 2014. Insights into the early epidemic spread of Ebola in Sierra Leone provided by viral sequence data. PloS Curr Outbreaks 1:1–18.
68. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee. 2007. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am JInfect Control 35:S65–S164. http://dx.doi.org/10.1016/j.ajic.2007.10.007.
69. Jones RM, Brosseau LM. 2014. Ebola virus transmission via contact and aerosol—a new paradigm. Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN. http://www.cidrap.umn.edu/news-perspective/2014/11/commentary-ebola-virus-transmission-contact-and-aerosol-new-paradigm.
70. Papineni RS, Rosenthal FS. 1997. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 10:105–116. http://dx.doi.org/10.1089/jam.1997.10.105.
71. Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Har-greaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoshevski D. 2009. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 40:122–133. http://dx.doi.org/10.1016/j.jaerosci.2008.10.003.
72. Zayas G, Chiang MC, Wong E, MacDonald F, Lange CF, Senthilselvan A, King M. 2012. Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectious respiratory disease management. BMC Pulm Med 12:11. http://dx.doi.org/10.1186/1471-2466-12-11.
73. Bourouiba L, Dehandschoewercker E, Bush J. 2014. Violent expiratory events: on coughing and sneezing. J Fluid Mech 745:537–563. http://dx.doi.org/10.1017/jfm.2014.88.
74. Gralton J, Tovey E, McLaws M-L, Rawlinson WD. 2011. The role of particle size in aerosolised pathogen transmission: a review. J Infect 62: 1–13. http://dx.doi.org/10.1016/j.jinf.2010.11.010.
75. Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. 2003. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect 131:727–736. http://dx.doi.org/10.1017/S0950268803008689.
76. Roy CJ, Milton DK. 2004. Airborne transmission of communicable in-fection—the elusive pathway. N Engl J Med 350:1710–1712. http://dx.doi.org/10.1056/NEJMp048051.
77. Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB. 2003. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77:5902–5910. http://dx.doi.org/10.1128/JVI.77.10.5902-5910.2003.
78. Decker BK, Sevransky JE, Barrett K, Davey RT, Chertow DS. 2014. Preparing for critical care services to patients with Ebola. Ann Intern Med 161:831–832. http://dx.doi.org/10.7326/M14-2141.
79. Irving WL. 1995. Ebola virus transmission. Int J Exp Pathol 76:225–226.
80. Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL, Stroh G, Casals J, Henderson BE. 1972. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 66:402–408. http://dx.doi.org/10.1016/0035-9203(72)90271-4.
81. Monath TP. 1975. Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ 52:577–592.
82. Pshenichnaya NY, Nenadskaya SA. 2015. Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis 33: 120–122. http://dx.doi.org/10.1016/j.ijid.2014.12.047.
83. Borio L, Schmaljohn AL, James M, Jahrling PB, Ksiazek T, Karl M, Meyerhoff A, Toole TO, Michael S, Bartlett J, Breman JG, Eitzen EM, Hamburg M, Hauer J, Henderson DA, Johnson RT, Layton M, Lil-libridge S, Gary J, Michael T, Russell P. 2002. Hemorrhagic fever viruses as biological weapons. JAMA 287:2391–2405. http://dx.doi.org/10.1001/jama.287.18.2391.
84. Leffel EK, Reed DS. 2004. Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2:186–191. http://dx.doi.org/10.1089/bsp.2004.2.186.
85. WHO. 2014. What we know about transmission of the Ebola virus among humans. http://www.who.int/mediacentre/news/ebola/06-october-2014/en/.
86. CDC. 2014. Why Ebola is not likely to become airborne. http://www.cdc.gov/vhf/ebola/pdf/mutations.pdf.